Phase 3 Study Of Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Canrenone (Primary)
- Indications Chronic heart failure
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms AREA-IN-CHF
- 03 Feb 2021 Biomarkers information updated
- 05 May 2009 Additional lead trial centre (Heart Care Foundation) added as reported by ClinicalTrials.gov
- 05 May 2009 Actual end date (1 Jul 2006) added as reported by ClinicalTrials.gov